Emergex Vaccines Holding Limited’s Competitors, Revenue, Number of Employees, Funding, Acquisitions & News

Emergex Vaccines is a biotechnology company that develops and commercializes vaccines for viral and bacterial infectious diseases. Read more

Emergex Vaccines is a biotechnology company that develops and commercializes vaccines for viral and bacterial infectious diseases. Read more

Thomas Rademacher's photo - Co-Founder & CEO of Emergex Vaccines Holding Limited

Co-Founder & CEO

Thomas Rademacher

CEO Approval Rating

90/100

Founded:

2016

Status:

Est. Annual Revenue
Est. Employees

TOP COMPETITORS OR ALTERNATIVES

RANK

COMPANY

CEO

CEO RATING

EMPLOYEES

FUNDING

REVENUE

Missing a competitor? Contribute!

Moderna, Inc. is Emergex Vaccines Holding Limited's #1 rival. Moderna, Inc. was founded in 2010 in Cambridge, Massachusetts. Like Emergex Vaccines Holding Limited, Moderna, Inc. also operates in the Biotechnology space. Moderna, Inc. generates $102.3M more revenue than Emergex Vaccines Holding Limited.

Zymeworks is one of Emergex Vaccines Holding Limited's top competitors. Zymeworks is headquartered in Vancouver, British Columbia, and was founded in 2003. Like Emergex Vaccines Holding Limited, Zymeworks also works within the Biotechnology sector. Zymeworks generates 867% the revenue of Emergex Vaccines Holding Limited.

XBiotech is seen as one of Emergex Vaccines Holding Limited's top competitors. XBiotech was founded in 2005, and its headquarters is in Austin, Texas. Like Emergex Vaccines Holding Limited, XBiotech also works within the Biotechnology sector. XBiotech has 49 more employees than Emergex Vaccines Holding Limited.

Weigh-in!

Help the Owler community know more

Growth Score - 1/1

Is 11 a good estimate for Emergex Vaccines Holding Limited's Employee count?

Acquisitions

No recent acquisitions found related to Emergex Vaccines Holding Limited

Emergex Vaccines Holding Limited Funding History

$11M

Since Emergex Vaccines Holding Limited was founded in 2016, it has participated in 1 round of funding. In total Emergex Vaccines Holding Limited has raised $11.0M. Emergex Vaccines Holding Limited's funding round was on Jan 2020 for a total of $11.0M

ROUND

FUNDING DATE

AMOUNT

INVESTORS

Series A
Jan 2020
$11M

Vickers Venture Partners

Total Funding: $11M

Since Emergex Vaccines Holding Limited was founded in 2016, it has participated in 1 round of funding. In total Emergex Vaccines Holding Limited has raised $11.0M. Emergex Vaccines Holding Limited's funding round was on Jan 2020 for a total of $11.0M

Investments

No recent investments found related to Emergex Vaccines Holding Limited

Emergex Vaccines Holding Limited News

April 23, 2020Pharmaceutical Business Review

Emergex signs agreement with George Mason University for highly pathogenic RNA virus studies

The agreement specifies that George Mason University's National Center for Biodefense and Infectious ... See more »
April 22, 2020firstwordpharma

Emergex Signs Agreement with GEORGE MASON UNIVERSITY for Highly Pathogenic RNA Virus Studies

ABINGDON, England--(BUSINESS WIRE)-- Emergex Vaccines Holding Limited ('Emergex'), a biotechnology co... See more »
January 13, 2020BioPortfolio

Emergex raises more than US$11 million in a Series A Round to Progress its Pipeline of Setpoint Vaccines for Infectious Diseases.

Emergex develops setpoint vaccines to prevent some of the world's most immediate and virulent disease... See more »
January 10, 2020EU-Startups

UK startup Emergex Vaccines raises more than €9.9 million to progress its vaccines for Zika, Dengue Fever and Ebola

Abingdon-based Emergex Vaccines, a biotech startup developing set-point vaccines to prevent serious i... See more »
January 10, 2020Volanews

SG's Vickers Venture leads $11m funding in biotech firm Emergex Vaccines

Proceeds will also support the Universal Influenza and Filovirus programmes through the preclinical s... See more »
December 12, 2019Medical Buyer

Emergex Completes Vaccine Candidate Against Intracellular & Francisella Tularensis

Emergex Vaccines Holding Limited A biotechnology company developing set-point vaccines to prevent ser... See more »
December 10, 2019Medical Buyer

Emergex Successfully Completes Preclinical Testing Of Its Lead 'Set-Point'

Emergex Vaccines Holding Limited ('Emergex'), a biotechnology company developing population-based syn... See more »

Emergex Vaccines Holding Limited Press Releases

Headquarters

4/5 Dunmore Court Wootton Road

London, EnglandOX13 6BH

44-123-552-7589

Driving Directions »

Trending Companies

Summary

ABOUT

Overview

Emergex Vaccines is a biotechnology company that develops and commercializes vaccines for viral and bacterial infectious diseases. Emergex Vaccines Holding Limited was founded in 2016. Emergex Vaccines Holding Limited's headquarters is located in Lond...

CEO

Emergex Vaccines Holding Limited's Co-Founder & CEO, Thomas Rademacher, currently has an approval rating of 90%. Emergex Vaccines Holding Limited's primary competitors are Moderna, Inc., Zymeworks & XBiotech.

Website

emergexvaccines.com

Frequently Asked Questions about Emergex Vaccines Holding Limited

  1. When was Emergex Vaccines Holding Limited founded?

    Emergex Vaccines Holding Limited was founded in 2016
  2. Who is Emergex Vaccines Holding Limited's CEO?

    Emergex Vaccines Holding Limited's CEO is Thomas Rademacher
  3. How much revenue does Emergex Vaccines Holding Limited generate?

    Emergex Vaccines Holding Limited generates $3.5M in revenue
  4. How much funding does Emergex Vaccines Holding Limited have?

    Emergex Vaccines Holding Limited has historically raised $11M in funding
  1. Where is Emergex Vaccines Holding Limited's headquarters?

    Emergex Vaccines Holding Limited's headquarters is in London England, GB
  2. How many employees does Emergex Vaccines Holding Limited have?

    Emergex Vaccines Holding Limited has 11 employees
  3. What sector does Emergex Vaccines Holding Limited operate in?

    Emergex Vaccines Holding Limited is in Biotechnology
  4. Who are Emergex Vaccines Holding Limited's competitors?

    Emergex Vaccines Holding Limited's top competitors are Moderna, Inc., Zymeworks, XBiotech